![Adrian Rawcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Rawcliffe
Directeur/Bestuurslid bij
WAVE LIFE SCIENCES LTD.
Vermogen: 2 637 $ op 31-05-2026
Profiel
Adrian Rawcliffe is currently Chief Executive Officer at Etiome, Inc. since 2026, Chief Executive Officer & Director at Adaptimmune Ltd. since 2019, Director at Morphotek, Inc., Independent Director at Wave Life Sciences Ltd. since 2017, Director at Wave Life Sciences USA, Inc., and Chief Financial Officer at Human Genome Sciences, Inc. since 2012.
Former roles include Chief Executive Officer & Director at Adaptimmune Therapeutics Plc from 2019 to 2025, Managing Partner at GSK Equity Investments Ltd. from 2005 to 2006, Senior Vice President-Finance at GSK Plc from 2011 to 2015, Senior Vice President-Finance at GlaxoSmithKline Biologicals SA, and Principal at AlgoRx Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Durham, conferred in 1993.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-04-2025 | 2.371.362 ( 0,15% ) | 2 371 $ | 31-05-2026 | |
| 17-01-2025 | 44.327 ( 0,02% ) | 266 $ | 31-05-2026 | |
| 27-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Adrian Rawcliffe
| Bedrijven | Functie | Begin |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Directeur/Bestuurslid | 01-02-2017 |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Directeur/Bestuurslid | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Financieel Directeur/CFO | 30-07-2012 |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Directeur/Bestuurslid | - |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Algemeen Directeur | 01-09-2019 |
Flagship Labs 84, Inc.
 Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Algemeen Directeur | 08-01-2026 |
Eerdere bekende functies van Adrian Rawcliffe
| Bedrijven | Functie | Einde |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Algemeen Directeur | 14-11-2025 |
| GSK PLC | Corporate Officer/Principal | 01-01-2015 |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Corporate Officer/Principal | 18-02-2009 |
| ░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Adrian Rawcliffe
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Morphotek, Inc.
Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Utilities |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
